

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of water loss via skin (GO:0033561) | 9.77939764 |
| 2 | keratinization (GO:0031424) | 9.60445089 |
| 3 | vitamin D metabolic process (GO:0042359) | 7.69911517 |
| 4 | multicellular organismal water homeostasis (GO:0050891) | 6.90267174 |
| 5 | vitamin biosynthetic process (GO:0009110) | 6.83871284 |
| 6 | keratinocyte proliferation (GO:0043616) | 6.70992780 |
| 7 | keratinocyte differentiation (GO:0030216) | 6.07522697 |
| 8 | water homeostasis (GO:0030104) | 5.86870416 |
| 9 | peptide cross-linking (GO:0018149) | 5.83887465 |
| 10 | surfactant homeostasis (GO:0043129) | 5.71368841 |
| 11 | molting cycle (GO:0042303) | 5.59247256 |
| 12 | hair cycle (GO:0042633) | 5.59247256 |
| 13 | positive regulation of chemokine secretion (GO:0090197) | 5.50245027 |
| 14 | thrombin receptor signaling pathway (GO:0070493) | 5.42096338 |
| 15 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 5.35583734 |
| 16 | positive regulation of antigen processing and presentation (GO:0002579) | 5.34705444 |
| 17 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 5.05391259 |
| 18 | detection of bacterium (GO:0016045) | 5.02314604 |
| 19 | epidermal cell differentiation (GO:0009913) | 4.93288950 |
| 20 | intermediate filament organization (GO:0045109) | 4.92321416 |
| 21 | L-phenylalanine catabolic process (GO:0006559) | 4.89134871 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.89134871 |
| 23 | regulation of chemokine secretion (GO:0090196) | 4.88941194 |
| 24 | lipoxygenase pathway (GO:0019372) | 4.81889026 |
| 25 | bile acid biosynthetic process (GO:0006699) | 4.65955246 |
| 26 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.51240076 |
| 27 | L-phenylalanine metabolic process (GO:0006558) | 4.51240076 |
| 28 | chemical homeostasis within a tissue (GO:0048875) | 4.49994720 |
| 29 | aromatic amino acid family catabolic process (GO:0009074) | 4.46831222 |
| 30 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.41763252 |
| 31 | detection of other organism (GO:0098543) | 4.38039082 |
| 32 | alpha-linolenic acid metabolic process (GO:0036109) | 4.37789034 |
| 33 | polyol biosynthetic process (GO:0046173) | 4.37418561 |
| 34 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.37001160 |
| 35 | regulation of antigen processing and presentation (GO:0002577) | 4.32992256 |
| 36 | epidermis development (GO:0008544) | 4.29098476 |
| 37 | biotin metabolic process (GO:0006768) | 4.05651608 |
| 38 | regulation of protein activation cascade (GO:2000257) | 4.03796744 |
| 39 | tryptophan catabolic process (GO:0006569) | 4.01701221 |
| 40 | indole-containing compound catabolic process (GO:0042436) | 4.01701221 |
| 41 | indolalkylamine catabolic process (GO:0046218) | 4.01701221 |
| 42 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.94855139 |
| 43 | regulation of triglyceride catabolic process (GO:0010896) | 3.83887797 |
| 44 | regulation of complement activation (GO:0030449) | 3.81931492 |
| 45 | urea metabolic process (GO:0019627) | 3.81777438 |
| 46 | urea cycle (GO:0000050) | 3.81777438 |
| 47 | complement activation, alternative pathway (GO:0006957) | 3.81262823 |
| 48 | bile acid metabolic process (GO:0008206) | 3.80989251 |
| 49 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.79889475 |
| 50 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.76065352 |
| 51 | negative regulation of protein activation cascade (GO:2000258) | 3.74480924 |
| 52 | amino-acid betaine metabolic process (GO:0006577) | 3.72474630 |
| 53 | regulation of fibrinolysis (GO:0051917) | 3.72289759 |
| 54 | high-density lipoprotein particle remodeling (GO:0034375) | 3.71238970 |
| 55 | tryptophan metabolic process (GO:0006568) | 3.69675825 |
| 56 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.67989011 |
| 57 | negative regulation of fibrinolysis (GO:0051918) | 3.67954476 |
| 58 | kynurenine metabolic process (GO:0070189) | 3.64713107 |
| 59 | nitrogen cycle metabolic process (GO:0071941) | 3.63257243 |
| 60 | desmosome organization (GO:0002934) | 3.62083504 |
| 61 | phospholipid efflux (GO:0033700) | 3.59685113 |
| 62 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.57617298 |
| 63 | protein carboxylation (GO:0018214) | 3.57617298 |
| 64 | detection of external biotic stimulus (GO:0098581) | 3.56274486 |
| 65 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.54937250 |
| 66 | hair follicle morphogenesis (GO:0031069) | 3.51202081 |
| 67 | glyoxylate metabolic process (GO:0046487) | 3.47239051 |
| 68 | negative regulation of lipase activity (GO:0060192) | 3.46797116 |
| 69 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.46023658 |
| 70 | regulation of cholesterol esterification (GO:0010872) | 3.41431946 |
| 71 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.40148561 |
| 72 | regulation of keratinocyte differentiation (GO:0045616) | 3.39459124 |
| 73 | negative regulation of complement activation (GO:0045916) | 3.36743418 |
| 74 | hemidesmosome assembly (GO:0031581) | 3.35894694 |
| 75 | fatty acid elongation (GO:0030497) | 3.35754800 |
| 76 | carnitine metabolic process (GO:0009437) | 3.34276138 |
| 77 | regulation of cholesterol metabolic process (GO:0090181) | 3.33966725 |
| 78 | regulation of hypersensitivity (GO:0002883) | 3.30086844 |
| 79 | skin morphogenesis (GO:0043589) | 3.27081929 |
| 80 | plasma lipoprotein particle clearance (GO:0034381) | 3.27060008 |
| 81 | homocysteine metabolic process (GO:0050667) | 3.26747897 |
| 82 | fibrinolysis (GO:0042730) | 3.26729145 |
| 83 | cellular biogenic amine catabolic process (GO:0042402) | 3.22700238 |
| 84 | amine catabolic process (GO:0009310) | 3.22700238 |
| 85 | serine family amino acid catabolic process (GO:0009071) | 3.21844153 |
| 86 | sulfur amino acid catabolic process (GO:0000098) | 3.20601137 |
| 87 | fat-soluble vitamin metabolic process (GO:0006775) | 3.20465195 |
| 88 | primary alcohol catabolic process (GO:0034310) | 3.19953260 |
| 89 | protein kinase C signaling (GO:0070528) | 3.18013787 |
| 90 | purinergic receptor signaling pathway (GO:0035587) | 3.17285597 |
| 91 | acylglycerol homeostasis (GO:0055090) | 3.16614303 |
| 92 | triglyceride homeostasis (GO:0070328) | 3.16614303 |
| 93 | plasma lipoprotein particle remodeling (GO:0034369) | 3.15671532 |
| 94 | protein-lipid complex remodeling (GO:0034368) | 3.15671532 |
| 95 | macromolecular complex remodeling (GO:0034367) | 3.15671532 |
| 96 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 3.13878662 |
| 97 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 3.13434147 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11216596 |
| 99 | regulation of phospholipase A2 activity (GO:0032429) | 3.10892416 |
| 100 | reverse cholesterol transport (GO:0043691) | 3.09244862 |
| 101 | detection of biotic stimulus (GO:0009595) | 3.08983648 |
| 102 | alpha-amino acid catabolic process (GO:1901606) | 3.08344305 |
| 103 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 3.07754027 |
| 104 | cyclooxygenase pathway (GO:0019371) | 3.07668144 |
| 105 | adhesion of symbiont to host cell (GO:0044650) | 3.04788002 |
| 106 | virion attachment to host cell (GO:0019062) | 3.04788002 |
| 107 | negative regulation of cholesterol transport (GO:0032375) | 3.02569191 |
| 108 | negative regulation of sterol transport (GO:0032372) | 3.02569191 |
| 109 | glutamate metabolic process (GO:0006536) | 3.01337251 |
| 110 | very long-chain fatty acid metabolic process (GO:0000038) | 3.01309416 |
| 111 | intermediate filament cytoskeleton organization (GO:0045104) | 3.00608126 |
| 112 | imidazole-containing compound metabolic process (GO:0052803) | 3.00520304 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 2.99717347 |
| 114 | cysteine metabolic process (GO:0006534) | 2.98865326 |
| 115 | aromatic amino acid family metabolic process (GO:0009072) | 2.98568234 |
| 116 | short-chain fatty acid metabolic process (GO:0046459) | 2.97064091 |
| 117 | regulation of natural killer cell differentiation (GO:0032823) | 2.93484859 |
| 118 | establishment of tissue polarity (GO:0007164) | 2.93192986 |
| 119 | establishment of planar polarity (GO:0001736) | 2.93192986 |
| 120 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.92515533 |
| 121 | ethanol oxidation (GO:0006069) | 2.91803255 |
| 122 | tyrosine metabolic process (GO:0006570) | 2.91603116 |
| 123 | cholesterol homeostasis (GO:0042632) | 2.90860979 |
| 124 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.88781638 |
| 125 | T-helper 1 type immune response (GO:0042088) | 2.88756713 |
| 126 | peptide catabolic process (GO:0043171) | 2.88517715 |
| 127 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.88308316 |
| 128 | linoleic acid metabolic process (GO:0043651) | 2.86947504 |
| 129 | intermediate filament-based process (GO:0045103) | 2.86619769 |
| 130 | histone H3-K36 demethylation (GO:0070544) | 2.85827374 |
| 131 | positive regulation of granulocyte chemotaxis (GO:0071624) | 2.84493311 |
| 132 | positive regulation of T cell cytokine production (GO:0002726) | 2.84173378 |
| 133 | retinol metabolic process (GO:0042572) | 2.83497886 |
| 134 | sterol homeostasis (GO:0055092) | 2.82983565 |
| 135 | ethanol metabolic process (GO:0006067) | 2.82669009 |
| 136 | one-carbon compound transport (GO:0019755) | 2.80244642 |
| 137 | bile acid and bile salt transport (GO:0015721) | 2.79947333 |
| 138 | complement activation (GO:0006956) | 2.79089955 |
| 139 | protein activation cascade (GO:0072376) | 2.78312023 |
| 140 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.78166854 |
| 141 | cholesterol efflux (GO:0033344) | 2.77823039 |
| 142 | cellular amino acid catabolic process (GO:0009063) | 2.77742378 |
| 143 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.76421918 |
| 144 | complement activation, classical pathway (GO:0006958) | 2.75901780 |
| 145 | iron ion import (GO:0097286) | 2.75147903 |
| 146 | cellular ketone body metabolic process (GO:0046950) | 2.74264625 |
| 147 | arginine metabolic process (GO:0006525) | 2.71952665 |
| 148 | negative regulation of blood coagulation (GO:0030195) | 2.70831416 |
| 149 | negative regulation of hemostasis (GO:1900047) | 2.70831416 |
| 150 | lateral sprouting from an epithelium (GO:0060601) | 2.70440018 |
| 151 | immunoglobulin mediated immune response (GO:0016064) | 2.69643122 |
| 152 | adhesion of symbiont to host (GO:0044406) | 2.63607136 |
| 153 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.59334711 |
| 154 | polyol transport (GO:0015791) | 2.58527786 |
| 155 | polarized epithelial cell differentiation (GO:0030859) | 2.53517841 |
| 156 | negative thymic T cell selection (GO:0045060) | 2.53326873 |
| 157 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.53030040 |
| 158 | negative regulation of humoral immune response (GO:0002921) | 2.51589339 |
| 159 | modulation by symbiont of host defense response (GO:0052031) | 2.50657040 |
| 160 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.50657040 |
| 161 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.50657040 |
| 162 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.50657040 |
| 163 | modulation by symbiont of host immune response (GO:0052553) | 2.50657040 |
| 164 | positive regulation by symbiont of host defense response (GO:0052509) | 2.50657040 |
| 165 | phosphatidylcholine acyl-chain remodeling (GO:0036151) | 2.48084214 |
| 166 | primary alcohol metabolic process (GO:0034308) | 2.47692507 |
| 167 | phosphatidylethanolamine acyl-chain remodeling (GO:0036152) | 2.46207598 |
| 168 | macrophage activation involved in immune response (GO:0002281) | 2.46195093 |
| 169 | gap junction assembly (GO:0016264) | 2.43433559 |
| 170 | negative regulation of interferon-gamma production (GO:0032689) | 2.43278547 |
| 171 | molting cycle process (GO:0022404) | 2.40966722 |
| 172 | hair cycle process (GO:0022405) | 2.40966722 |
| 173 | regulation of chemokine-mediated signaling pathway (GO:0070099) | 2.39716569 |
| 174 | phosphatidylglycerol acyl-chain remodeling (GO:0036148) | 2.39271810 |
| 175 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.39010369 |
| 176 | NIK/NF-kappaB signaling (GO:0038061) | 2.36484805 |
| 177 | positive regulation of type 2 immune response (GO:0002830) | 2.35603405 |
| 178 | glycosphingolipid catabolic process (GO:0046479) | 2.33192175 |
| 179 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.31071523 |
| 180 | unsaturated fatty acid biosynthetic process (GO:0006636) | 2.30135505 |
| 181 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.29208728 |
| 182 | endothelium development (GO:0003158) | 2.28663324 |
| 183 | positive regulation of epidermis development (GO:0045684) | 2.27756463 |
| 184 | positive regulation of neutrophil migration (GO:1902624) | 2.27325006 |
| 185 | positive regulation of neutrophil chemotaxis (GO:0090023) | 2.27325006 |
| 186 | fat-soluble vitamin biosynthetic process (GO:0042362) | 16.5890972 |
| 187 | establishment of skin barrier (GO:0061436) | 11.2547511 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 7.12700763 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.23203299 |
| 3 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 6.10052365 |
| 4 | GATA1_22025678_ChIP-Seq_K562_Human | 4.15787812 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.15132546 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.88283165 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.66250573 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.40416065 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.37456925 |
| 10 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.24914846 |
| 11 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.89758515 |
| 12 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.56671984 |
| 13 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.24599453 |
| 14 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.09999110 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.02297311 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.96193011 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.90363083 |
| 18 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.87329352 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.83446642 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.79993059 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.75916817 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.75452122 |
| 23 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.72773645 |
| 24 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.51619376 |
| 25 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44950116 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.43474783 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42673517 |
| 28 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41839657 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.40708905 |
| 30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.39940404 |
| 31 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.39373731 |
| 32 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.39121465 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.35697537 |
| 34 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33865384 |
| 35 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.33729121 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30303867 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.29968618 |
| 38 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.29266545 |
| 39 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.28131075 |
| 40 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.27328416 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.26999301 |
| 42 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.26866225 |
| 43 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.26479648 |
| 44 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24839285 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22258557 |
| 46 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.20961066 |
| 47 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20277583 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.20039563 |
| 49 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19161145 |
| 50 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.18439099 |
| 51 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.16648057 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16004426 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15856152 |
| 54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14646873 |
| 55 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12680902 |
| 56 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11805793 |
| 57 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.10893497 |
| 58 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10877118 |
| 59 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08516526 |
| 60 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.08402196 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.06547739 |
| 62 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05776992 |
| 63 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05070208 |
| 64 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.04912360 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03866762 |
| 66 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.01889031 |
| 67 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01857776 |
| 68 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01857776 |
| 69 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.98867781 |
| 70 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.98826406 |
| 71 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97265874 |
| 72 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96690690 |
| 73 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.96367910 |
| 74 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.94018752 |
| 75 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93249429 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.92471193 |
| 77 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91962392 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.91750970 |
| 79 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91568788 |
| 80 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89950679 |
| 81 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.88983071 |
| 82 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88858848 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88616000 |
| 84 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.88562083 |
| 85 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88451674 |
| 86 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88317137 |
| 87 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.88155081 |
| 88 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.87200659 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87101110 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86850611 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86369390 |
| 92 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.85708774 |
| 93 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.85392023 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.85148117 |
| 95 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.84749464 |
| 96 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.84749464 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.84427337 |
| 98 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84331987 |
| 99 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84036915 |
| 100 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.81938107 |
| 101 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.81886695 |
| 102 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.81710451 |
| 103 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.81353948 |
| 104 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.81242162 |
| 105 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.81066511 |
| 106 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80743102 |
| 107 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.80582317 |
| 108 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.80400819 |
| 109 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80069460 |
| 110 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.79802142 |
| 111 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.78019749 |
| 112 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.77300930 |
| 113 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.77223436 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.77002691 |
| 115 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.75373373 |
| 116 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74220028 |
| 117 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.74174691 |
| 118 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.73941780 |
| 119 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.73353720 |
| 120 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.72419290 |
| 121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72151126 |
| 122 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.72064411 |
| 123 | GATA1_19941826_ChIP-Seq_K562_Human | 0.71861820 |
| 124 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.71175310 |
| 125 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.71028605 |
| 126 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.70831178 |
| 127 | CBP_21632823_ChIP-Seq_H3396_Human | 0.70822275 |
| 128 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.70711235 |
| 129 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.70353915 |
| 130 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.70049116 |
| 131 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.70049116 |
| 132 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.69997566 |
| 133 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69504663 |
| 134 | RXR_22108803_ChIP-Seq_LS180_Human | 0.69234027 |
| 135 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.68633865 |
| 136 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.67936263 |
| 137 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.66744580 |
| 138 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.65790369 |
| 139 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.64448860 |
| 140 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.64369641 |
| 141 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.63843827 |
| 142 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.63212309 |
| 143 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.61966203 |
| 144 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61950987 |
| 145 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61950987 |
| 146 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.61442341 |
| 147 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.61242857 |
| 148 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.61135153 |
| 149 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.60335467 |
| 150 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.60271071 |
| 151 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.60127509 |
| 152 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.59857275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.23085407 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.16564006 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.65969415 |
| 4 | MP0009379_abnormal_foot_pigmentation | 4.29450280 |
| 5 | MP0004381_abnormal_hair_follicle | 4.16515801 |
| 6 | MP0002796_impaired_skin_barrier | 4.09437998 |
| 7 | MP0005365_abnormal_bile_salt | 4.08079304 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 3.96956249 |
| 9 | MP0010234_abnormal_vibrissa_follicle | 3.56679751 |
| 10 | MP0005451_abnormal_body_composition | 3.25368373 |
| 11 | MP0001188_hyperpigmentation | 2.74690535 |
| 12 | MP0010329_abnormal_lipoprotein_level | 2.54425279 |
| 13 | MP0005083_abnormal_biliary_tract | 2.48297754 |
| 14 | MP0003252_abnormal_bile_duct | 2.44353809 |
| 15 | MP0002095_abnormal_skin_pigmentation | 2.26387970 |
| 16 | MP0005275_abnormal_skin_tensile | 2.22305623 |
| 17 | MP0000427_abnormal_hair_cycle | 2.19702311 |
| 18 | MP0001853_heart_inflammation | 2.15414998 |
| 19 | MP0002060_abnormal_skin_morphology | 2.14596649 |
| 20 | MP0000015_abnormal_ear_pigmentation | 2.03140189 |
| 21 | MP0001243_abnormal_dermal_layer | 2.02926183 |
| 22 | MP0005409_darkened_coat_color | 1.99230167 |
| 23 | MP0003879_abnormal_hair_cell | 1.98273258 |
| 24 | MP0005501_abnormal_skin_physiology | 1.89680686 |
| 25 | MP0003806_abnormal_nucleotide_metabolis | 1.89517568 |
| 26 | MP0004947_skin_inflammation | 1.86533829 |
| 27 | MP0000647_abnormal_sebaceous_gland | 1.81044467 |
| 28 | MP0009840_abnormal_foam_cell | 1.79983401 |
| 29 | MP0005332_abnormal_amino_acid | 1.77493131 |
| 30 | MP0002254_reproductive_system_inflammat | 1.74877029 |
| 31 | MP0003195_calcinosis | 1.73911446 |
| 32 | MP0005075_abnormal_melanosome_morpholog | 1.72430260 |
| 33 | MP0003436_decreased_susceptibility_to | 1.71973442 |
| 34 | MP0005174_abnormal_tail_pigmentation | 1.70381888 |
| 35 | MP0000566_synostosis | 1.64880331 |
| 36 | MP0002118_abnormal_lipid_homeostasis | 1.64875451 |
| 37 | MP0004782_abnormal_surfactant_physiolog | 1.60101943 |
| 38 | MP0010678_abnormal_skin_adnexa | 1.58024787 |
| 39 | MP0001666_abnormal_nutrient_absorption | 1.57592529 |
| 40 | MP0000609_abnormal_liver_physiology | 1.53862120 |
| 41 | MP0001216_abnormal_epidermal_layer | 1.53678696 |
| 42 | MP0001835_abnormal_antigen_presentation | 1.48550259 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.46834596 |
| 44 | MP0002102_abnormal_ear_morphology | 1.46592885 |
| 45 | MP0003191_abnormal_cellular_cholesterol | 1.43340513 |
| 46 | MP0009764_decreased_sensitivity_to | 1.42598639 |
| 47 | MP0010771_integument_phenotype | 1.40742064 |
| 48 | MP0008004_abnormal_stomach_pH | 1.35127290 |
| 49 | MP0003878_abnormal_ear_physiology | 1.35043368 |
| 50 | MP0005377_hearing/vestibular/ear_phenot | 1.35043368 |
| 51 | MP0000685_abnormal_immune_system | 1.34516887 |
| 52 | MP0003941_abnormal_skin_development | 1.34316594 |
| 53 | MP0003566_abnormal_cell_adhesion | 1.25642252 |
| 54 | MP0004142_abnormal_muscle_tone | 1.21533523 |
| 55 | MP0005670_abnormal_white_adipose | 1.19403689 |
| 56 | MP0004019_abnormal_vitamin_homeostasis | 1.19115843 |
| 57 | MP0003724_increased_susceptibility_to | 1.17830624 |
| 58 | MP0000377_abnormal_hair_follicle | 1.09019535 |
| 59 | MP0003303_peritoneal_inflammation | 1.08886446 |
| 60 | MP0005503_abnormal_tendon_morphology | 1.08582881 |
| 61 | MP0003453_abnormal_keratinocyte_physiol | 1.08493479 |
| 62 | MP0002138_abnormal_hepatobiliary_system | 1.07265177 |
| 63 | MP0010352_gastrointestinal_tract_polyps | 1.05249746 |
| 64 | MP0004185_abnormal_adipocyte_glucose | 1.03256806 |
| 65 | MP0000579_abnormal_nail_morphology | 1.01541551 |
| 66 | MP0001851_eye_inflammation | 1.00520053 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.97637883 |
| 68 | MP0004742_abnormal_vestibular_system | 0.97388690 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 0.97037798 |
| 70 | MP0005058_abnormal_lysosome_morphology | 0.96594321 |
| 71 | MP0001958_emphysema | 0.94369498 |
| 72 | MP0000383_abnormal_hair_follicle | 0.92368279 |
| 73 | MP0008438_abnormal_cutaneous_collagen | 0.91469470 |
| 74 | MP0005647_abnormal_sex_gland | 0.91031683 |
| 75 | MP0004510_myositis | 0.89835293 |
| 76 | MP0000367_abnormal_coat/_hair | 0.88573290 |
| 77 | MP0009643_abnormal_urine_homeostasis | 0.88142407 |
| 78 | MP0000467_abnormal_esophagus_morphology | 0.87686470 |
| 79 | MP0005671_abnormal_response_to | 0.86824092 |
| 80 | MP0005023_abnormal_wound_healing | 0.84959600 |
| 81 | MP0009931_abnormal_skin_appearance | 0.82839802 |
| 82 | MP0004264_abnormal_extraembryonic_tissu | 0.82411184 |
| 83 | MP0000604_amyloidosis | 0.81315334 |
| 84 | MP0002998_abnormal_bone_remodeling | 0.81200111 |
| 85 | MP0003448_altered_tumor_morphology | 0.80737598 |
| 86 | MP0001346_abnormal_lacrimal_gland | 0.80333507 |
| 87 | MP0005387_immune_system_phenotype | 0.80223883 |
| 88 | MP0001790_abnormal_immune_system | 0.80223883 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.79172033 |
| 90 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77714668 |
| 91 | MP0001800_abnormal_humoral_immune | 0.76519991 |
| 92 | MP0005666_abnormal_adipose_tissue | 0.73688852 |
| 93 | MP0001845_abnormal_inflammatory_respons | 0.73654322 |
| 94 | MP0002452_abnormal_antigen_presenting | 0.72924099 |
| 95 | MP0008469_abnormal_protein_level | 0.72748771 |
| 96 | MP0009333_abnormal_splenocyte_physiolog | 0.72018297 |
| 97 | MP0004130_abnormal_muscle_cell | 0.71957747 |
| 98 | MP0003828_pulmonary_edema | 0.71867172 |
| 99 | MP0002419_abnormal_innate_immunity | 0.71006378 |
| 100 | MP0009763_increased_sensitivity_to | 0.70959803 |
| 101 | MP0003705_abnormal_hypodermis_morpholog | 0.70454856 |
| 102 | MP0003763_abnormal_thymus_physiology | 0.70175914 |
| 103 | MP0005334_abnormal_fat_pad | 0.69744435 |
| 104 | MP0008874_decreased_physiological_sensi | 0.69145388 |
| 105 | * MP0002148_abnormal_hypersensitivity_rea | 0.68967371 |
| 106 | MP0003279_aneurysm | 0.68355987 |
| 107 | MP0001533_abnormal_skeleton_physiology | 0.68151526 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.68026491 |
| 109 | MP0003045_fibrosis | 0.67276966 |
| 110 | MP0001191_abnormal_skin_condition | 0.66216196 |
| 111 | MP0002133_abnormal_respiratory_system | 0.65871974 |
| 112 | MP0005388_respiratory_system_phenotype | 0.65871974 |
| 113 | * MP0005025_abnormal_response_to | 0.65706664 |
| 114 | MP0001542_abnormal_bone_strength | 0.65430705 |
| 115 | MP0002098_abnormal_vibrissa_morphology | 0.65342076 |
| 116 | MP0005000_abnormal_immune_tolerance | 0.65278918 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.64415980 |
| 118 | MP0003300_gastrointestinal_ulcer | 0.64334720 |
| 119 | MP0003638_abnormal_response/metabolism_ | 0.62874125 |
| 120 | MP0005165_increased_susceptibility_to | 0.62824335 |
| 121 | MP0001348_abnormal_lacrimal_gland | 0.62222191 |
| 122 | MP0002009_preneoplasia | 0.60729530 |
| 123 | MP0000627_abnormal_mammary_gland | 0.59810871 |
| 124 | MP0009642_abnormal_blood_homeostasis | 0.59483798 |
| 125 | MP0003075_altered_response_to | 0.58774451 |
| 126 | MP0003011_delayed_dark_adaptation | 0.58632037 |
| 127 | MP0002837_dystrophic_cardiac_calcinosis | 0.58609523 |
| 128 | MP0000598_abnormal_liver_morphology | 0.58327954 |
| 129 | MP0003690_abnormal_glial_cell | 0.57965996 |
| 130 | MP0003868_abnormal_feces_composition | 0.56630960 |
| 131 | MP0006082_CNS_inflammation | 0.56289541 |
| 132 | MP0009785_altered_susceptibility_to | 0.54926912 |
| 133 | MP0002971_abnormal_brown_adipose | 0.54086693 |
| 134 | MP0005390_skeleton_phenotype | 0.53889120 |
| 135 | MP0001784_abnormal_fluid_regulation | 0.53543847 |
| 136 | MP0000858_altered_metastatic_potential | 0.53366250 |
| 137 | MP0000762_abnormal_tongue_morphology | 0.52937959 |
| 138 | MP0003718_maternal_effect | 0.52830333 |
| 139 | MP0001819_abnormal_immune_cell | 0.52481362 |
| 140 | MP0003091_abnormal_cell_migration | 0.52460040 |
| 141 | MP0002405_respiratory_system_inflammati | 0.52448910 |
| 142 | MP0010155_abnormal_intestine_physiology | 0.52289810 |
| 143 | MP0002277_abnormal_respiratory_mucosa | 0.51977865 |
| 144 | MP0002723_abnormal_immune_serum | 0.51685520 |
| 145 | MP0003183_abnormal_peptide_metabolism | 0.51190281 |
| 146 | MP0002420_abnormal_adaptive_immunity | 0.50135539 |
| 147 | MP0005248_abnormal_Harderian_gland | 0.47404788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thin bony cortex (HP:0002753) | 9.47803205 |
| 2 | Widely patent fontanelles and sutures (HP:0004492) | 8.19060054 |
| 3 | Enlarged epiphyses (HP:0010580) | 7.39795766 |
| 4 | Delayed epiphyseal ossification (HP:0002663) | 7.29078320 |
| 5 | Erythroderma (HP:0001019) | 6.32036829 |
| 6 | Abnormality of the costochondral junction (HP:0000919) | 6.15767725 |
| 7 | Conjunctival hamartoma (HP:0100780) | 5.98983874 |
| 8 | Erythema (HP:0010783) | 5.70561599 |
| 9 | Alopecia of scalp (HP:0002293) | 5.36135615 |
| 10 | Flat occiput (HP:0005469) | 5.29806110 |
| 11 | Abnormality of the axillary hair (HP:0100134) | 5.27951695 |
| 12 | Abnormality of secondary sexual hair (HP:0009888) | 5.27951695 |
| 13 | Wide cranial sutures (HP:0010537) | 5.16561093 |
| 14 | Thick nail (HP:0001805) | 5.04113974 |
| 15 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.76928141 |
| 16 | Intrahepatic cholestasis (HP:0001406) | 4.58109268 |
| 17 | Rickets (HP:0002748) | 4.48730850 |
| 18 | Abnormality of nail color (HP:0100643) | 4.45558443 |
| 19 | Deep venous thrombosis (HP:0002625) | 4.43075364 |
| 20 | Xanthomatosis (HP:0000991) | 4.42295457 |
| 21 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.40720748 |
| 22 | Tibial bowing (HP:0002982) | 4.08753675 |
| 23 | Epidermoid cyst (HP:0200040) | 4.05539971 |
| 24 | Metaphyseal irregularity (HP:0003025) | 4.01111301 |
| 25 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.90168965 |
| 26 | Hamartoma of the eye (HP:0010568) | 3.89930828 |
| 27 | Prolonged partial thromboplastin time (HP:0003645) | 3.85070430 |
| 28 | Hyperammonemia (HP:0001987) | 3.71563719 |
| 29 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.66545715 |
| 30 | Pili torti (HP:0003777) | 3.59579922 |
| 31 | Complement deficiency (HP:0004431) | 3.52222804 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 3.46651013 |
| 33 | Abnormality of complement system (HP:0005339) | 3.34893544 |
| 34 | Progressive hearing impairment (HP:0001730) | 3.34784598 |
| 35 | Abnormal blistering of the skin (HP:0008066) | 3.34573348 |
| 36 | Abnormal hair laboratory examination (HP:0003328) | 3.33413517 |
| 37 | Parakeratosis (HP:0001036) | 3.28364713 |
| 38 | Gangrene (HP:0100758) | 3.22116631 |
| 39 | Femoral bowing (HP:0002980) | 3.21886952 |
| 40 | Hypophosphatemia (HP:0002148) | 3.16392381 |
| 41 | Corneal erosion (HP:0200020) | 3.14821210 |
| 42 | Hypobetalipoproteinemia (HP:0003563) | 3.06531084 |
| 43 | Fragile nails (HP:0001808) | 3.01617454 |
| 44 | Palmoplantar keratoderma (HP:0000982) | 2.99260566 |
| 45 | Bone pain (HP:0002653) | 2.92139104 |
| 46 | Elevated alkaline phosphatase (HP:0003155) | 2.90772822 |
| 47 | Hypergammaglobulinemia (HP:0010702) | 2.89182366 |
| 48 | Hyperglycinemia (HP:0002154) | 2.81466402 |
| 49 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.77197973 |
| 50 | Hypoalphalipoproteinemia (HP:0003233) | 2.73833218 |
| 51 | Joint hemorrhage (HP:0005261) | 2.72369220 |
| 52 | Xerostomia (HP:0000217) | 2.72094943 |
| 53 | Sparse scalp hair (HP:0002209) | 2.69128929 |
| 54 | Abnormal trabecular bone morphology (HP:0100671) | 2.64595005 |
| 55 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.64302276 |
| 56 | Hypolipoproteinemia (HP:0010981) | 2.63300648 |
| 57 | Abnormal epiphyseal ossification (HP:0010656) | 2.61446317 |
| 58 | Myocardial infarction (HP:0001658) | 2.59740615 |
| 59 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.57774878 |
| 60 | Ridged nail (HP:0001807) | 2.56672527 |
| 61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.56300448 |
| 62 | Abnormality of the salivary glands (HP:0010286) | 2.55077920 |
| 63 | Difficulty walking (HP:0002355) | 2.51956138 |
| 64 | Sparse eyelashes (HP:0000653) | 2.50519092 |
| 65 | Abnormality of glycine metabolism (HP:0010895) | 2.46384039 |
| 66 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.46384039 |
| 67 | Abnormality of glycolipid metabolism (HP:0010969) | 2.44872288 |
| 68 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.44872288 |
| 69 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.44872288 |
| 70 | Right ventricular cardiomyopathy (HP:0011663) | 2.43685890 |
| 71 | Hypotrichosis (HP:0001006) | 2.39701417 |
| 72 | Abnormality of the common coagulation pathway (HP:0010990) | 2.38291208 |
| 73 | Ketosis (HP:0001946) | 2.38152854 |
| 74 | Absent eyelashes (HP:0000561) | 2.37085256 |
| 75 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.33714633 |
| 76 | Osteolytic defects of the hand bones (HP:0009699) | 2.33714633 |
| 77 | Abnormal cortical bone morphology (HP:0003103) | 2.32549101 |
| 78 | Melanocytic nevus (HP:0000995) | 2.31921058 |
| 79 | Submucous cleft hard palate (HP:0000176) | 2.29699936 |
| 80 | Lip pit (HP:0100267) | 2.29656240 |
| 81 | Amyloidosis (HP:0011034) | 2.26401008 |
| 82 | Nail dystrophy (HP:0008404) | 2.26289872 |
| 83 | Systemic lupus erythematosus (HP:0002725) | 2.23745604 |
| 84 | Distal lower limb muscle weakness (HP:0009053) | 2.22829324 |
| 85 | Milia (HP:0001056) | 2.21631994 |
| 86 | Fat malabsorption (HP:0002630) | 2.20871189 |
| 87 | Periodontitis (HP:0000704) | 2.18311920 |
| 88 | Increased IgE level (HP:0003212) | 2.16647955 |
| 89 | Hypohidrosis (HP:0000966) | 2.15870767 |
| 90 | Blepharitis (HP:0000498) | 2.15658219 |
| 91 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15465410 |
| 92 | Urticaria (HP:0001025) | 2.14247735 |
| 93 | Cerebral palsy (HP:0100021) | 2.14109551 |
| 94 | Abnormality of the dental root (HP:0006486) | 2.13922390 |
| 95 | Taurodontia (HP:0000679) | 2.13922390 |
| 96 | Abnormality of permanent molar morphology (HP:0011071) | 2.13922390 |
| 97 | Pruritus (HP:0000989) | 2.13685101 |
| 98 | Slow-growing hair (HP:0002217) | 2.11531193 |
| 99 | Abnormality of hair growth rate (HP:0011363) | 2.11531193 |
| 100 | Recurrent skin infections (HP:0001581) | 2.10307843 |
| 101 | Hypercholesterolemia (HP:0003124) | 2.09581021 |
| 102 | Nephritis (HP:0000123) | 2.09281510 |
| 103 | Abnormality of the dental pulp (HP:0006479) | 2.09077350 |
| 104 | Hamartoma (HP:0010566) | 2.08086854 |
| 105 | Hypoplastic labia majora (HP:0000059) | 2.06522436 |
| 106 | Mediastinal lymphadenopathy (HP:0100721) | 2.04317742 |
| 107 | Conjugated hyperbilirubinemia (HP:0002908) | 2.04004080 |
| 108 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.01761730 |
| 109 | Abnormality of molar (HP:0011077) | 2.00989844 |
| 110 | Abnormality of molar morphology (HP:0011070) | 2.00989844 |
| 111 | Skin ulcer (HP:0200042) | 2.00798228 |
| 112 | Abnormality of placental membranes (HP:0011409) | 2.00573193 |
| 113 | Amniotic constriction ring (HP:0009775) | 2.00573193 |
| 114 | Hyperglycinuria (HP:0003108) | 2.00455707 |
| 115 | Glomerulonephritis (HP:0000099) | 1.97247236 |
| 116 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.96882751 |
| 117 | Abnormality of methionine metabolism (HP:0010901) | 1.96215755 |
| 118 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.95676585 |
| 119 | Villous atrophy (HP:0011473) | 1.95676585 |
| 120 | Spontaneous hematomas (HP:0007420) | 1.95013493 |
| 121 | Palmoplantar hyperkeratosis (HP:0000972) | 1.94632764 |
| 122 | Thoracic kyphosis (HP:0002942) | 1.94015295 |
| 123 | Advanced eruption of teeth (HP:0006288) | 1.92453220 |
| 124 | Natal tooth (HP:0000695) | 1.89820819 |
| 125 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.89638104 |
| 126 | Mucopolysacchariduria (HP:0008155) | 1.88194945 |
| 127 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.88194945 |
| 128 | Ankyloglossia (HP:0010296) | 1.86898188 |
| 129 | Skin nodule (HP:0200036) | 1.86789281 |
| 130 | Malignant hyperthermia (HP:0002047) | 1.85111706 |
| 131 | Coarse hair (HP:0002208) | 1.84577823 |
| 132 | Abnormality of the labia majora (HP:0012881) | 1.84507171 |
| 133 | Abnormality of the lumbar spine (HP:0100712) | 1.84263543 |
| 134 | Abnormality of serum amino acid levels (HP:0003112) | 1.83943029 |
| 135 | Abnormality of the gastric mucosa (HP:0004295) | 1.83284319 |
| 136 | Metaphyseal cupping (HP:0003021) | 1.82216353 |
| 137 | Hyporeflexia of lower limbs (HP:0002600) | 1.80153971 |
| 138 | Dry hair (HP:0011359) | 1.80145900 |
| 139 | Absent hand (HP:0004050) | 1.78804530 |
| 140 | Hematochezia (HP:0002573) | 1.78512913 |
| 141 | Selective tooth agenesis (HP:0001592) | 1.77263501 |
| 142 | Hyperbilirubinemia (HP:0002904) | 1.76938022 |
| 143 | Colitis (HP:0002583) | 1.75491372 |
| 144 | Ketoacidosis (HP:0001993) | 1.74497272 |
| 145 | Palmar hyperkeratosis (HP:0010765) | 1.74045890 |
| 146 | Abnormality of the Achilles tendon (HP:0005109) | 1.73989163 |
| 147 | Hyperactive renin-angiotensin system (HP:0000841) | 1.73670068 |
| 148 | Vacuolated lymphocytes (HP:0001922) | 1.73602383 |
| 149 | Depressed nasal tip (HP:0000437) | 1.72344164 |
| 150 | Absent hair (HP:0002298) | 1.72297095 |
| 151 | Oral leukoplakia (HP:0002745) | 1.72281111 |
| 152 | Acanthosis nigricans (HP:0000956) | 1.72233135 |
| 153 | Interstitial pulmonary disease (HP:0006530) | 1.72075890 |
| 154 | Plantar hyperkeratosis (HP:0007556) | 1.70909917 |
| 155 | Abnormality of the intrinsic pathway (HP:0010989) | 1.70769863 |
| 156 | Dysostosis multiplex (HP:0000943) | 1.70449228 |
| 157 | Aplasia cutis congenita (HP:0001057) | 1.70106380 |
| 158 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.69632980 |
| 159 | Recurrent cutaneous fungal infections (HP:0011370) | 1.69632980 |
| 160 | Abnormality of the fibula (HP:0002991) | 1.69322226 |
| 161 | Increased cerebral lipofuscin (HP:0011813) | 1.69171990 |
| 162 | Onycholysis (HP:0001806) | 1.69056586 |
| 163 | Popliteal pterygium (HP:0009756) | 1.68952978 |
| 164 | Split foot (HP:0001839) | 1.68876334 |
| 165 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.68123630 |
| 166 | Woolly hair (HP:0002224) | 1.66770640 |
| 167 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.65842835 |
| 168 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.65842835 |
| 169 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.65842835 |
| 170 | Stomatitis (HP:0010280) | 1.65035658 |
| 171 | Eczematoid dermatitis (HP:0000976) | 1.64248796 |
| 172 | Coronal craniosynostosis (HP:0004440) | 1.63959960 |
| 173 | Spontaneous abortion (HP:0005268) | 1.63826835 |
| 174 | Ectropion (HP:0000656) | 1.63213098 |
| 175 | Steatorrhea (HP:0002570) | 1.62665322 |
| 176 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.62390226 |
| 177 | Nasolacrimal duct obstruction (HP:0000579) | 1.62300993 |
| 178 | Recurrent bacterial skin infections (HP:0005406) | 1.62014019 |
| 179 | Premature loss of primary teeth (HP:0006323) | 1.60971599 |
| 180 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.59099380 |
| 181 | Aplasia of the phalanges of the hand (HP:0009802) | 1.59099380 |
| 182 | Aplasia involving bones of the extremities (HP:0009825) | 1.59099380 |
| 183 | Hyperhidrosis (HP:0000975) | 1.57923622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK24 | 5.86049242 |
| 2 | MAP3K9 | 5.10295829 |
| 3 | MST1R | 4.94095953 |
| 4 | MAP3K13 | 4.75634618 |
| 5 | TGFBR1 | 4.05776593 |
| 6 | ARAF | 3.96925065 |
| 7 | BLK | 3.43364868 |
| 8 | EEF2K | 3.20662569 |
| 9 | KSR2 | 2.88700040 |
| 10 | RIPK4 | 2.76225063 |
| 11 | MAP3K6 | 2.73170802 |
| 12 | MAPKAPK3 | 2.72271320 |
| 13 | MOS | 2.37938727 |
| 14 | FGFR3 | 2.24063657 |
| 15 | RIPK1 | 2.23302149 |
| 16 | PIK3CG | 2.11388486 |
| 17 | TRIB3 | 2.01595397 |
| 18 | EPHA3 | 1.99767955 |
| 19 | CDC42BPA | 1.90262428 |
| 20 | ZAP70 | 1.82982908 |
| 21 | PTK6 | 1.72716861 |
| 22 | TYK2 | 1.50979812 |
| 23 | MET | 1.44396247 |
| 24 | BCKDK | 1.41044785 |
| 25 | JAK3 | 1.39130892 |
| 26 | PRPF4B | 1.37430549 |
| 27 | BMPR2 | 1.31681873 |
| 28 | CDK3 | 1.30876531 |
| 29 | STK3 | 1.30569746 |
| 30 | TBK1 | 1.30504400 |
| 31 | TRPM7 | 1.24840508 |
| 32 | RAF1 | 1.18151111 |
| 33 | NEK9 | 1.15464015 |
| 34 | BRAF | 1.15386856 |
| 35 | MAPKAPK5 | 1.15146323 |
| 36 | FGFR1 | 1.13928289 |
| 37 | FGFR4 | 1.13845100 |
| 38 | LATS1 | 1.13620617 |
| 39 | EPHA2 | 1.11179528 |
| 40 | YES1 | 1.09965431 |
| 41 | CDK6 | 1.08636480 |
| 42 | EIF2AK2 | 1.06576917 |
| 43 | ERN1 | 1.06493715 |
| 44 | MAP2K1 | 1.05619286 |
| 45 | EPHB1 | 1.05245542 |
| 46 | KSR1 | 1.04347337 |
| 47 | JAK2 | 1.00945041 |
| 48 | CDK12 | 0.99763636 |
| 49 | INSRR | 0.98087034 |
| 50 | MAPK12 | 0.94706806 |
| 51 | PDGFRB | 0.92093286 |
| 52 | TAOK3 | 0.91502017 |
| 53 | GRK1 | 0.90428668 |
| 54 | SIK1 | 0.89919291 |
| 55 | PRKD2 | 0.89311844 |
| 56 | MATK | 0.86621515 |
| 57 | MUSK | 0.86380372 |
| 58 | TGFBR2 | 0.84243369 |
| 59 | PRKAA2 | 0.81433327 |
| 60 | MAP3K2 | 0.81241825 |
| 61 | LIMK1 | 0.80191811 |
| 62 | IRAK1 | 0.78898540 |
| 63 | MAP3K14 | 0.78883730 |
| 64 | CAMK1D | 0.76824692 |
| 65 | MAP3K1 | 0.76285649 |
| 66 | FGR | 0.76136518 |
| 67 | CSK | 0.73880954 |
| 68 | FES | 0.72331490 |
| 69 | MARK2 | 0.71854308 |
| 70 | IKBKE | 0.70922163 |
| 71 | PRKACG | 0.69561855 |
| 72 | CAMK1 | 0.68639689 |
| 73 | DMPK | 0.67428809 |
| 74 | MAP2K6 | 0.67327896 |
| 75 | RPS6KB2 | 0.66449798 |
| 76 | MAP2K4 | 0.65390912 |
| 77 | RET | 0.64780805 |
| 78 | ICK | 0.63388896 |
| 79 | MAPK4 | 0.62008572 |
| 80 | JAK1 | 0.61345490 |
| 81 | MAPK7 | 0.59521583 |
| 82 | RPS6KB1 | 0.57762856 |
| 83 | ERBB4 | 0.57720801 |
| 84 | NLK | 0.57360518 |
| 85 | DAPK2 | 0.56332276 |
| 86 | RPS6KA5 | 0.55285539 |
| 87 | IGF1R | 0.55055050 |
| 88 | TTN | 0.54493871 |
| 89 | TAOK2 | 0.53441926 |
| 90 | CSF1R | 0.52390937 |
| 91 | LRRK2 | 0.50868410 |
| 92 | KIT | 0.49962861 |
| 93 | SYK | 0.49910931 |
| 94 | MAPK15 | 0.49634041 |
| 95 | EPHA4 | 0.48931731 |
| 96 | DYRK1B | 0.48521777 |
| 97 | PDGFRA | 0.47876963 |
| 98 | SMG1 | 0.47509009 |
| 99 | GSK3A | 0.47186899 |
| 100 | FER | 0.45968986 |
| 101 | CAMK1G | 0.45941645 |
| 102 | WNK1 | 0.44367323 |
| 103 | MAP3K8 | 0.43789541 |
| 104 | PDK1 | 0.43720041 |
| 105 | ABL2 | 0.43607136 |
| 106 | RPS6KA4 | 0.43153296 |
| 107 | PRKCB | 0.42686514 |
| 108 | ERBB2 | 0.42024389 |
| 109 | IKBKB | 0.41956515 |
| 110 | BTK | 0.41701368 |
| 111 | CAMK2D | 0.41080120 |
| 112 | HIPK2 | 0.41071451 |
| 113 | SGK3 | 0.40969579 |
| 114 | MAP4K1 | 0.40863455 |
| 115 | PKN1 | 0.40101889 |
| 116 | SGK223 | 0.39364871 |
| 117 | SGK494 | 0.39364871 |
| 118 | FYN | 0.38550851 |
| 119 | PIM2 | 0.37710845 |
| 120 | BRD4 | 0.37298585 |
| 121 | NEK6 | 0.37191660 |
| 122 | PDPK1 | 0.36735730 |
| 123 | MTOR | 0.36528491 |
| 124 | SGK2 | 0.36345046 |
| 125 | PTK2 | 0.35122689 |
| 126 | ABL1 | 0.34907735 |
| 127 | LYN | 0.34168735 |
| 128 | CHUK | 0.34155415 |
| 129 | PRKACA | 0.32993172 |
| 130 | ITK | 0.32404428 |
| 131 | RPS6KA2 | 0.30881134 |
| 132 | HCK | 0.29816791 |
| 133 | MAPKAPK2 | 0.29747282 |
| 134 | PRKD1 | 0.29071936 |
| 135 | DDR2 | 0.28895607 |
| 136 | PRKCD | 0.28493160 |
| 137 | MAP3K3 | 0.25927929 |
| 138 | MAP3K7 | 0.24933769 |
| 139 | PRKG1 | 0.24772611 |
| 140 | CDK5 | 0.24653239 |
| 141 | GRK6 | 0.24231747 |
| 142 | FGFR2 | 0.22224175 |
| 143 | PRKACB | 0.21643760 |
| 144 | CAMKK1 | 0.21623637 |
| 145 | PRKCA | 0.20390388 |
| 146 | FLT3 | 0.20262550 |
| 147 | STK10 | 0.19840149 |
| 148 | GRK7 | 0.19750180 |
| 149 | MAPK3 | 0.19725612 |
| 150 | SGK1 | 0.19213437 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.48645877 |
| 2 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.10311348 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.90403481 |
| 4 | Asthma_Homo sapiens_hsa05310 | 3.20803937 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.98278323 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.97704242 |
| 7 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.95907668 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.80016141 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.70358788 |
| 10 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61953919 |
| 11 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.61441911 |
| 12 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.51025438 |
| 13 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.47084425 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.42095323 |
| 15 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.41353174 |
| 16 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.32072554 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.22723971 |
| 18 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.16949040 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.09437283 |
| 20 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08687398 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03156464 |
| 22 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.02658073 |
| 23 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.02160359 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.85345139 |
| 25 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85282684 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84249390 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.83619550 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80107561 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.77093066 |
| 30 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.73376113 |
| 31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.72320615 |
| 32 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.70700405 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.69318814 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.65170799 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.64814437 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.63457247 |
| 37 | Tuberculosis_Homo sapiens_hsa05152 | 1.59510933 |
| 38 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.52154531 |
| 39 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.49205684 |
| 40 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.46583541 |
| 41 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44837033 |
| 42 | Other glycan degradation_Homo sapiens_hsa00511 | 1.44539522 |
| 43 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.41604101 |
| 44 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.40650408 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.39679034 |
| 46 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.36582178 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 1.31714919 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.31068957 |
| 49 | Phagosome_Homo sapiens_hsa04145 | 1.30615045 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.29927070 |
| 51 | Influenza A_Homo sapiens_hsa05164 | 1.22199074 |
| 52 | Bile secretion_Homo sapiens_hsa04976 | 1.19540878 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.14065617 |
| 54 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09049723 |
| 55 | Retinol metabolism_Homo sapiens_hsa00830 | 1.05896467 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.05410359 |
| 57 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.03671760 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.03640461 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.01540486 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.98387254 |
| 61 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.97400235 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.94421735 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92190320 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.87867884 |
| 65 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.86001832 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 0.84520130 |
| 67 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.83928215 |
| 68 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.79772057 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77853462 |
| 70 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77180550 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.75672825 |
| 72 | Mineral absorption_Homo sapiens_hsa04978 | 0.74417194 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.73172245 |
| 74 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.72013707 |
| 75 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71519122 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.68644189 |
| 77 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.68134463 |
| 78 | Lysine degradation_Homo sapiens_hsa00310 | 0.67619348 |
| 79 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67134917 |
| 80 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66598696 |
| 81 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.66560365 |
| 82 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.66215184 |
| 83 | Malaria_Homo sapiens_hsa05144 | 0.65747815 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.65147298 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.64555004 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.63595818 |
| 87 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63276795 |
| 88 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.63167298 |
| 89 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62762438 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.61918983 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | 0.61018589 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.60662350 |
| 93 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.60561818 |
| 94 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59130232 |
| 95 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58387418 |
| 96 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.57809405 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56470281 |
| 98 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.52681283 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.52311039 |
| 100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51921315 |
| 101 | Renin secretion_Homo sapiens_hsa04924 | 0.51901228 |
| 102 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.50761936 |
| 103 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.50428848 |
| 104 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.50414932 |
| 105 | Adherens junction_Homo sapiens_hsa04520 | 0.49996644 |
| 106 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49983849 |
| 107 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48035671 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.47340565 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46056346 |
| 110 | Carbon metabolism_Homo sapiens_hsa01200 | 0.44888302 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44265818 |
| 112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.44126425 |
| 113 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.42755774 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42547705 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.42076013 |
| 116 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.40964016 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.39559448 |
| 118 | Measles_Homo sapiens_hsa05162 | 0.38748128 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.36184335 |
| 120 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35742617 |
| 121 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.35058079 |
| 122 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34634518 |
| 123 | Hepatitis C_Homo sapiens_hsa05160 | 0.34044325 |
| 124 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32943337 |
| 125 | Long-term depression_Homo sapiens_hsa04730 | 0.32702599 |
| 126 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.30612758 |
| 127 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30548027 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30391261 |
| 129 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.30361319 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.29665278 |
| 131 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28493123 |
| 132 | Lysosome_Homo sapiens_hsa04142 | 0.27714941 |
| 133 | Focal adhesion_Homo sapiens_hsa04510 | 0.27605166 |
| 134 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27561520 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.26937009 |
| 136 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.26426694 |
| 137 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26185966 |
| 138 | Bladder cancer_Homo sapiens_hsa05219 | 0.25714584 |
| 139 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.22649270 |
| 140 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.22047878 |
| 141 | Amoebiasis_Homo sapiens_hsa05146 | 0.21489698 |
| 142 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.21034677 |
| 143 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.20134932 |
| 144 | Metabolic pathways_Homo sapiens_hsa01100 | 0.17108275 |
| 145 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16055665 |
| 146 | Leishmaniasis_Homo sapiens_hsa05140 | 0.15917061 |
| 147 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15469748 |
| 148 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.14376397 |
| 149 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.12817450 |
| 150 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.12806162 |
| 151 | Insulin resistance_Homo sapiens_hsa04931 | 0.11924109 |
| 152 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.10398773 |
| 153 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.10031829 |
| 154 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09509136 |
| 155 | Pertussis_Homo sapiens_hsa05133 | 0.09499537 |
| 156 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.07944128 |
| 157 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.05398609 |
| 158 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04507187 |
| 159 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04415880 |
| 160 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.01805549 |
| 161 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | -0.0059122 |
| 162 | ErbB signaling pathway_Homo sapiens_hsa04012 | -0.0046991 |

